Syneron Medical Ltd (ELOS)

[midastouch017]

Syneron Announces Additional Regulatory Clearances in Q2 2005
Tuesday June 28, 8:30 am ET
Rate of Regulatory Clearances Worldwide for elos(TM) Products Continues Strongly


YOKNEAM, ISRAEL and TORONTO--(MARKET WIRE)--Jun 28, 2005 -- Syneron Medical Ltd. (NasdaqNM:ELOS - News) announced that during Q2 2005 it received FDA clearances for two new Syneron applicators and was also granted additional regulatory clearances in several other markets.


The FDA cleared Syneron's new Aurora(TM) SR advanced applicator with broader specifications to treat superficial benign vascular and pigmented lesions. The FDA also granted clearance for Syneron's new advanced Aurora DS applicator with broader specifications for permanent hair reduction treatment. Both new applicators have been designed for use on the Aurora and Galaxy(TM) platforms.

Since March, Syneron has added three new regulatory clearances for the VelaSmooth(TM) system: Australia, Korea, and the Philippines. These new Asia-Pacific clearances follow regulatory clearances in the U.S., Canada, and Europe for the VelaSmooth, Syneron's medical device for the treatment of cellulite.

In Europe, Syneron received Medical CE Mark approval for its Comet(TM) high-speed hair removal system.

According to Syneron's head of regulatory and clinical affairs, Dr. Amir Waldman, "Syneron continues to strengthen its global leadership position with new product development and enhancements to our existing successful product offering. The momentum of clearances from regulatory authorities worldwide is testimony to the safety and efficacy of Syneron products and the elos(TM) technology on which they are based."

http://biz.yahoo.com/iw/050628/089690.html

Dubi